IL13Pred: A method for predicting immunoregulatory cytokine IL-13 inducing peptides

被引:0
|
作者
Jain, Shipra [1 ]
Dhall, Anjali [1 ]
Patiyal, Sumeet [1 ]
Raghava, Gajendra P.S. [1 ]
机构
[1] Department of Computational Biology, Indraprastha Institute of Information Technology, Okhla Phase 3, New Delhi,110020, India
关键词
COVID-19;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Interleukin 13 (IL-13) is an immunoregulatory cytokine, primarily released by activated T-helper 2 cells. IL-13 induces the pathogenesis of many allergic diseases, such as airway hyperresponsiveness, glycoprotein hypersecretion, and goblet cell hyperplasia. In addition, IL-13 inhibits tumor immunosurveillance, leading to carcinogenesis. Since elevated IL-13 serum levels are severe in COVID-19 patients, predicting IL-13 inducing peptides or regions in a protein is vital to designing safe protein therapeutics particularly immunotherapeutic. Objective: The present study describes a method to develop, predict, design, and scan IL-13 inducing peptides. Methods: The dataset experimentally validated 313 IL-13 inducing peptides, and 2908 non-inducing homo-sapiens peptides extracted from the immune epitope database (IEDB). A total of 95 key features using the linear support vector classifier with the L1 penalty (SVC-L1) technique was extracted from the originally generated 9165 features using Pfeature. These key features were ranked based on their prediction ability, and the top 10 features were used to build machine learning prediction models. Various machine learning techniques were deployed to develop models for predicting IL-13 inducing peptides. These models were trained, tested, and evaluated using five-fold cross-validation techniques; the best model was evaluated on an independent dataset. Results: Our best model based on XGBoost achieves a maximum AUC of 0.83 and 0.80 on the training and independent dataset, respectively. Our analysis indicates that certain SARS-COV2 variants are more prone to induce IL-13 in COVID-19 patients. Conclusion: The best performing model was incorporated in web-server and standalone package named ‘IL-13Pred’ for precise prediction of IL-13 inducing peptides. For large dataset analysis standalone package of IL-13Pred is available at (https://webs.iiitd.edu.in/raghava/il13pred/) webserver and over GitHub link: https://github.com/raghavagps/il13pred. © 2022 Elsevier Ltd
引用
收藏
相关论文
共 50 条
  • [1] IL13Pred: A method for predicting immunoregulatory cytokine IL-13 inducing peptides
    Jain, Shipra
    Dhall, Anjali
    Patiyal, Sumeet
    Raghava, Gajendra P. S.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 143
  • [2] iIL13Pred: improved prediction of IL-13 inducing peptides using popular machine learning classifiers
    Arora, Pooja
    Periwal, Neha
    Goyal, Yash
    Sood, Vikas
    Kaur, Baljeet
    BMC BIOINFORMATICS, 2023, 24 (01)
  • [3] iIL13Pred: improved prediction of IL-13 inducing peptides using popular machine learning classifiers
    Pooja Arora
    Neha Periwal
    Yash Goyal
    Vikas Sood
    Baljeet Kaur
    BMC Bioinformatics, 24
  • [4] Participation of IL-13 in the cytokine network of psoriasis
    Gudjonsson, Johann
    Xing, Xianying
    Riblett, MaryBeth
    Kochkodan, James
    Guzman, Andrew
    Elder, James
    Johnston, Andrew
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S15 - S15
  • [5] Role of IL-13 in the cytokine network of psoriasis
    Riblett, M.
    Xing, X.
    Kochkodan, J.
    Guzman, A. M.
    Voorhees, J. J.
    Johnston, A.
    Gudjonsson, J. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S3 - S3
  • [6] Genetics of IL-13 and functional relevance of IL-13 variants
    Vercelli, Donata
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 2 (05) : 389 - 393
  • [7] Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma
    Agrawal, Swati
    Townley, Robert G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) : 165 - 181
  • [8] Opposing roles for IL-13 and IL-13 receptor α2 in health and disease
    Mentink-Kane, MM
    Wynn, TA
    IMMUNOLOGICAL REVIEWS, 2004, 202 : 191 - 202
  • [9] IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease
    Mitchell, Jesse
    Dimov, Vesselin
    Townley, Robert G.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (05) : 527 - 534
  • [10] IMMUNOREGULATORY PROPERTIES OF IL-13 - ITS POTENTIAL ROLE IN ATOPIC DISEASE
    DEVRIES, JE
    ZURAWSKI, G
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 106 (03) : 175 - 179